by telrheum | Mar 11, 2024 | JAK Inhibitor, Biologic Therapy, Colitis, Rheumatoid Arthritis, Spondyloarthritis
Rinvoq, a newer medication in the field of rheumatology and immunology, has shown remarkable efficacy in managing several chronic inflammatory conditions. As a selective Janus kinase (JAK) inhibitor, Rinvoq specifically targets pathways that contribute to the...
by telrheum | Mar 11, 2024 | Rheumatoid Arthritis, Colitis, JAK Inhibitor
Xeljanz, known generically as tofacitinib, is a medication that represents a significant advancement in the treatment of various autoimmune diseases. Approved by the FDA, Xeljanz operates by inhibiting Janus kinase (JAK) pathways, which are crucial in the process of...
by telrheum | Mar 11, 2024 | Viral Infections, Biologic Therapy, Rheumatoid Arthritis, Spondyloarthritis
COVID-19, caused by the SARS-CoV-2 virus, has had wide-ranging impacts on global health since its emergence in late 2019. Among its many effects, there is a notable connection with arthritis, both in terms of how COVID-19 can affect individuals with existing arthritis...
by telrheum | Mar 9, 2024 | Biologic Therapy, Environmental, Spondyloarthritis
Tryptophan is a special kind of protein building block found in foods like meat and eggs. Scientists are looking into how it might affect a condition called spondyloarthritis. This is a form of arthritis that mainly hurts the spine but can also affect the arms, legs,...
by telrheum | Mar 8, 2024 | Biologic Therapy, Vasculitis
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare disease that causes inflammation in small blood vessels and involves a type of white blood cell called eosinophils. Benralizumab, a type of targeted therapy designed to block a specific part of the immune...
